Last 12mo stats

mentions

voices

$WVE

Wave Life Sciences Ltd

$WVE

Wave Life Sciences Ltd

Past 12mo:12mentions1voices

All voices12 mentions since Sep 2025calls only

Loading price chart…

Frequently asked

Who mentions $WVE most on Surfaced?

@adamfeuerstein (Adam Feuerstein ✡️) mentions $WVE most — 12 mentions in the past 12 months.

When was $WVE first mentioned on Surfaced?

The earliest tracked mention of $WVE in the Surfaced archive was on Sep 3, 2025.

How many voices track $WVE?

1 FinTwit voice has mentioned $WVE 12 times in the past 12 months.

What kind of voices mention $WVE most?

$WVE is mentioned most by Biotech voices on Surfaced.

Recent mentions

12 mentions

@adamfeuersteinMar 29, 2026 · 4:18 PM

@PeterKolchinsky Ok. I could draw up a similar list of targets, drug classes that never worked, despite a ton of time and money invested. You could, too. You invested heavily in $WVE and it sounds like you still believe in the company. Conviction is important. Best of luck to you.

Open on X

@adamfeuersteinMar 29, 2026 · 3:44 PM

@PeterKolchinsky Peter - I could connect you with a fund manager who shorted $WVE. His thesis proved correct and profitable. He’s very smart. Great track record on the biotech short side, for years.

Open on X

@adamfeuersteinMar 26, 2026 · 11:49 AM

$WVE -40%. The stock price losing a lot more weight than its do-nothing "body composition" drug. Remember... https://t.co/XATxYYS3zB

Open on X

@adamfeuersteinMar 26, 2026 · 11:42 AM

$WVE WVE-007 six-month data just released.... 1% placebo-adjusted weight loss! 🤣 https://t.co/DR0Au9V39m

Open on X

@adamfeuersteinMar 12, 2026 · 8:05 PM

Doing some reading ahead of the next wave of $WVE INHBE "body composition" 🙄 data, smirking at the Jefferies analyst set up, which basically frames 6-month data as a win-win-win for the stock price. His "bear case" "Bear case would still set WVE-007 up to be a viable option for obesity treatment given at low dose and early timepoint, but it may not be a strong monoTx, and instead potentially a maintenance or add-on/combo therapy with SoC."

Open on X

@adamfeuersteinFeb 2, 2026 · 12:45 PM

This is the Grade 5 SAE version of "our partner doesn't like or want our drug so they gave it back." Wave Life Sciences $WVE announces plans to accelerate regulatory engagement with full control of WVE-006 for alpha-1 antitrypsin deficiency

Open on X

@adamfeuersteinJan 6, 2026 · 1:13 PM

$ARWR another INHBE targeted drug with no weight loss. Missing 24-week data Miniscule Ns (and an omitted patient) in combo tirzepatide arm But hey, who needs data when you can just sell a cool story? Like $WVE

Open on X

@adamfeuersteinDec 11, 2025 · 12:51 PM

In this week's Biotech Scorecard newsletter: $WVE Wave’s ‘gym bro’ obesity drug is story over substance https://t.co/XATxYYS3zB

Open on X

@adamfeuersteinDec 8, 2025 · 9:06 PM

$2 billion of stock being offered tonight, collectively, from $GPCR $DYN $VERA $FULC $WVE $KYMR and it's only 4:06 pm.

Open on X

@adamfeuersteinDec 8, 2025 · 12:50 PM

$WVE We've entered the "patients are heavier is good!" phase of the obesity hype cycle.

Open on X

@adamfeuersteinDec 8, 2025 · 10:51 AM

Happy Monday morning! Should be a busy one, with weekend ASH stock trading + $KYMR $DYN $GPCR $WVE data readouts. And, of course, everyone will be buying more $ABVX

Open on X

@adamfeuersteinSep 3, 2025 · 1:48 PM

Your Wednesday AATD scorecard: $WVE down $BEAM up

Open on X